The Impact of Infection Versus Colonization on Clostridioides difficile Environmental Contamination in Hospitalized Patients With Diarrhea

Hot off the press from the DiRTE Lab, the newest addition to the DCASIP, Lab Director Bobby Warren and his team take us through their work studying environmental contamination from patients with CDI. 

Severe acute respiratory syndrome coronavirus 2 environmental contamination in hospital rooms is uncommon using viral culture techniques

Bobby Warren, DiRTE Lab (the newest branch of DCASIP) Director, and team assessed environmental contamination of inpatient rooms housing coronavirus disease 2019 (COVID-19) patients in a dedicated COVID-19 unit. Contamination with severe acute respiratory syndrome coronavirus 2 was found on 5.5% (19/347) of surfaces via reverse transcriptase polymerase chain reaction and 0.3% (1/347) of surfaces via cell culture. Environmental contamination is uncommon in hospitals rooms; RNA presence is not a specific indicator of infectious virus.

Surgical Site Infections: An Update

DICON faculty and SSI expert Dr. Jessie Seidelman and DICON Medical Director D. Dev Anderson provided an update on SSIs to the journal Infection Disease Clinics of North America. 

The impact of coronavirus disease 2019 (COVID-19) response on hospital infection prevention programs and practices in the southeastern United States

With DICON Co-Medical Director Dr. Sonali Advani leading, the DICON IP team took a look at the impact of COVID-19 response on hospital infection prevention programs and practices within the DICON network. 

Initial assessments of coronavirus disease 2019 (COVID-19) preparedness revealed resource shortages and variations in infection prevention policies across US hospitals. The follow-up survey revealed improvement in resource availability, increase in testing capacity, and uniformity in infection prevention policies. Most importantly, the survey highlighted an increase in staffing shortages and use of travel nursing.

Virtual Infection Prevention -The Next Frontier

DICON Medical Director, Dr. Dev Anderson, worked with a team from Virginia Commenwealth Univeristy in Richmond to explore the changing landscape of infection prevention and antimicrobial stewardship centered on virtual surveillance. 

Evaluation of Cloth Masks and Modified Procedure Masks as Personal Protective Equipment for the Public During the COVID-19 Pandemic

During the coronavirus disease 2019 (COVID-19) pandemic, the general public has been advised to wear masks or improvised face coverings to limit transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, there has been considerable confusion and disagreement regarding the degree to which masks protect the wearer from airborne particles.

DICON Medical Director, Dr. Dev Anderson, and the CDC Epicenters Program worked to evaluate the fitted filtration efficiency (FFE) of various consumer-grade and improvised face masks, as well as several popular modifications of medical procedure masks that are intended to improve mask fit or comfort.

Assessing SARS-CoV-2 Preparedness in US Community Hospitals: A Forgotten Entity

Associate DICON Medical Director, Dr. Sonali Advani, and the DICON IP team collected and analyzed data from DICON member hospitals to assess SARS-CoV-2 preparedness in community hospitals. 

WThe team performed a cross-sectional survey of infection preventionists in 60 US community hospitals between April 22 and May 8, 2020, and found several differences in hospital preparedness for SARS-CoV-2 with respect to personal protective equipment conservation strategies, protocols related to testing, universal masking and restarting elective procedures.

The NCBI listing can be found here

Racial, Ethnic, and Geographic Disparities in Novel Coronavirus (SARS-CoV-2) Test Positivity in North Carolina

Emerging evidence suggests that Black and Hispanic communities in the United States are disproportionately affected by coronavirus disease 2019 (COVID-19). A complex interplay of socioeconomic and healthcare disparities likely contribute to disproportionate COVID-19 risk. 

A Pediatric Infectious Disease Perspective of SARS-CoV-2 and COVID-19 in Children

Dr. Ibukun Akinboyo, from DUMC Pediatric Infectious Diseases and frequent supporter of DICON, worked with faculty from many medical centers to put together a pediatric infectious disease perspective of SARS-CoV-2 and COVID-19 in children for the Journal of the Pediatric Infectious Diseases Society. 

Are we Forgetting the "Universal" in Universal Masking? Current Challenges and Future Solutions

In this Letter to the Editor, published in Infection Control & Hospital Epidemiology, DICON Drs Sonali Advani, Mike Yarrginton, Becky Smith, Dev Anderson, and Dan Sexton discuss the importance of universal masking in healthcare settings.